We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Information is a powerful tool and West’s Knowledge Center has been updated to provide our customers with an improved user experience. We’ve completed a comprehensive overhaul of the Knowledge Center user interface, including a filter-based search design, more modern look and feel, and easy access to trending articles, new content, and FAQ’s answered by West Subject Matter Experts.
West strives to enable the safe and efficient delivery of drug products to patients. As part of that commitment, we launched the West Knowledge Center in 2017 to provide accurate and updated information on topics that impact both our customers and our industry. To date, we’ve supported the information needs of more than 3500 customers.
Our Knowledge Center resources include deep insight into market trends, scientific developments in parenteral packaging and delivery systems, and information on hot topics of interest to our customers, in a variety of content types, including technical reports and bulletins, posters and presentations, and links to webinars and helpful literature. In addition, our Technical Customer Support Portal, exclusively available for current and prospective customers, features:
FAQ articles from West Subject Matter Experts
Product information such as Formulation Characteristics, Drawings, Regulatory Compliance Bulletins, and Extractables
Support documents for products available for our online store such as Example Quality Certificates and Master Specifications
Click here to register for access to our Online Technical Repository, or for current and prospective customers, our Online Technical Customer Support Portal.
As always, our Technical Customer Service team is available to help – contact us today to discuss your needs.
The Standing Committee of the National People’s Congress in China passed the revised Drug Administration Law (Revised Law) on 26-Aug-19. Effective 1-Dec-19, it is the first overhaul since 2001.The Revised Law addresses the major issues in the pharmaceutical industry, demonstrating the government’s efforts in strengthening supervision to ensure drug safety.
In the pharmaceutical industry, safety and quality are paramount. One critical aspect of ensuring the safety of pharmaceutical products is extractables and leachables (E&L) testing. This testing process examines the potential migration of substances from containers, packaging materials, and drug delivery systems into the drug products themselves. By understanding the reasoning behind E&L testing, we can appreciate its role in protecting public health and enhancing customer trust. West Pharmaceutical Services, Inc. is a leader in developing comprehensive studies to evaluate container closure systems in real world simulations, providing customers with a better understanding of their leachable profile and how that could affect drug stability.
Cell and gene therapies are an expanding area with an expected growth rate of 24.7% over the forecast period of 2022-2030 .<sup>1</sup><br />Vial-stopper-seal combinations used as containment systems for these therapies need to maintain container closure integrity (CCI) for extended periods. Achieving CCI can be a particular challenge due to the low storage temperatures required: ultra-low (-80°C) for gene therapies and cryogenic (≤ -130°C, i.e., vapor of liquid nitrogen) for cell therapies.
West is now celebrating the one-year anniversary of its Integrated Solutions initiative, known as Simplify the Journey™. Throughout 2019, we socialized the program through marketing materials and face-to-face conversations with customers. Now it’s time to reflect on the lessons we’ve learned — and to look forward to the opportunities on the horizon.
Biosimilar development and approvals have been accelerated over the last several years. The rapid uptake in this category is due in large part to clarity on regulatory pathways that demonstrate interchangeability with the reference product and key patent expiry over the next decade. By 2025 injectable biosimilars are projected to comprise almost 50% of the accessible biologics market<sup>1</sup>. West recently conducted a survey of biosimilar companies to better understand their top needs for packaging and support services during drug development.